Please Note: This trial is no longer enrolling new participants
Phase I open-label dose escalation trial of BI 3923948 monotherapy and in combination with an anti-PD-1 mAb in patients with advanced, unresectable and/or metastatic solid tumors
| Protocol No. | CTO-1538-0001 | Scope | National |
|---|---|---|---|
| Principal Investigator | Mateusz Opyrchal | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
